Geneos Wealth Management’s Nuveen Real Asset Income & Growth Fund JRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,005
Closed -$122K 2847
2025
Q2
$122K Sell
9,005
-9,663
-52% -$123K ﹤0.01% 1170
2025
Q1
$242K Buy
18,668
+17,234
+1,202% +$219K ﹤0.01% 1153
2024
Q4
$17.4K Sell
1,434
-171
-11% -$2.24K ﹤0.01% 1799
2024
Q3
$21.9K Buy
+1,605
New +$20.5K ﹤0.01% 1532
2022
Q3
Sell
-1,216
Closed -$16K 2316
2022
Q2
$16K Hold
1,216
﹤0.01% 1782
2022
Q1
$18K Hold
1,216
﹤0.01% 1856
2021
Q4
$19K Hold
1,216
﹤0.01% 1908
2021
Q3
$18K Hold
1,216
﹤0.01% 1969
2021
Q2
$19K Hold
1,216
﹤0.01% 1940
2021
Q1
$18K Hold
1,216
﹤0.01% 2124
2020
Q4
$17K Hold
1,216
﹤0.01% 1997
2020
Q3
$14K Hold
1,216
﹤0.01% 1827
2020
Q2
$14K Buy
+1,216
New +$13.5K ﹤0.01% 1774
2018
Q2
Sell
-120
Closed -$1K 2294
2018
Q1
$1K Sell
120
-548
-82% -$9.29K ﹤0.01% 2105
2017
Q4
$11K Hold
668
﹤0.01% 1607
2017
Q3
$12K Buy
+668
New +$12.1K ﹤0.01% 1513

Other funds holding JRI

Geneos Wealth Management's JRI Position: Q3 2025 in Review

Geneos Wealth Management sold out of Nuveen Real Asset Income & Growth Fund (JRI) in Q3 2025, closing a stake of 9,005 shares — an estimated $122K sold.

Geneos Wealth Management first reported a position in JRI in Q3 2017 and held it in 16 quarters. The position peaked at $242K in Q1 2025. 68 funds tracked by Wall St. Rank hold JRI as of Q3 2025.

  • Geneos Wealth Management reported no remaining Nuveen Real Asset Income & Growth Fund position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 9,005 Nuveen Real Asset Income & Growth Fund shares in Q3 2025, an estimated $122K.
  • Geneos Wealth Management first reported a position in Nuveen Real Asset Income & Growth Fund in Q3 2017 and held it in 16 quarters.
  • Geneos Wealth Management's Nuveen Real Asset Income & Growth Fund position peaked at $242K in Q1 2025.
  • 68 funds tracked by Wall St. Rank held Nuveen Real Asset Income & Growth Fund as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.